TP53 mutation and microsatellite instability status for the prediction of survival in adjuvant-treated colon cancer patients

被引：1
|
作者：
Watanabe, T [1 ]
Kanazawa, T [1 ]
Kazama, Y [1 ]
Tanaka, J [1 ]
Tanaka, T [1 ]
Ishihara, S [1 ]
Nagawa, H [1 ]
机构：
[1] Tokyo Univ Hosp, Dept Surg Oncol, Tokyo 113, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 35期
关键词：
D O I：
10.1200/JCO.2005.04.0394
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：9031 / 9032
页数：2
相关论文
共 50 条
  • [21] Novel Mutations of the Suppressor Gene PTEN in Colorectal Carcinomas Stratified by Microsatellite Instability- and TP53 Mutation- Status
    Danielsen, Stine A.
    Lind, Guro E.
    Bjornslett, Merete
    Meling, Gunn I.
    Rognum, Torleiv O.
    Heim, Sverre
    Lothe, Ragnhild A.
    [J]. HUMAN MUTATION, 2008, 29 (11) : E252 - E262
  • [22] TP53 Mutation by CRISPR System Enhances the Malignant Potential of Colon Cancer
    Watanabe, Sho
    Tsuchiya, Kiichiro
    Nishimura, Ryu
    Shirasaki, Tomoaki
    Katsukura, Nobuhiro
    Hibiya, Shuji
    Okamoto, Ryuichi
    Nakamura, Tetsuya
    Watanabe, Mamoru
    [J]. MOLECULAR CANCER RESEARCH, 2019, 17 (07) : 1459 - 1467
  • [23] Concordance of p53 Immunohistochemistry and TP53 Mutation Status in Endometrial Cancer
    Paula, Arnaud Da Cruz
    DeLair, Deborah
    Fix, Daniel
    Soslow, Robert
    Park, Kay
    Chiang, Sarah
    Reis-Filho, Jorge
    Zehir, Ahmet
    Murali, Rajmohan
    Makker, Vicky
    Cadoo, Karen
    Mueller, Jennifer
    Leitao, Mario
    Abu-Rustum, Nadeem
    Aghajanian, Carol
    Weigelt, Britta
    [J]. MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1034 - 1035
  • [24] Concordance of p53 Immunohistochemistry and TP53 Mutation Status in Endometrial Cancer
    Paula, Arnaud Da Cruz
    DeLair, Deborah
    Fix, Daniel
    Soslow, Robert
    Park, Kay
    Chiang, Sarah
    Reis-Filho, Jorge
    Zehir, Ahmet
    Murali, Rajmohan
    Makker, Vicky
    Cadoo, Karen
    Mueller, Jennifer
    Leitao, Mario
    Abu-Rustum, Nadeem
    Aghajanian, Carol
    Weigelt, Britta
    [J]. LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1034 - 1035
  • [25] Combined KRAS and TP53 Mutation Status Is Not Predictive in CAPOX-treated Metastatic Colorectal Cancer
    De Bruijn, Menno T.
    Raats, Danielle A. E.
    Tol, Jolien
    Hinrichs, John
    Teerenstra, Steven
    Punt, Cornelis J. A.
    Rinkes, Inne H. M. Borel
    Kranenburg, Onno
    [J]. ANTICANCER RESEARCH, 2011, 31 (04) : 1379 - 1385
  • [26] Prognostic significance of K-ras and TP53 mutations in the role of adjuvant chemotherapy on survival in patients with Dukes C colon cancer
    Bleeker, WA
    Hayes, VM
    Karrenbeld, A
    Hofstra, RMW
    Verlind, E
    Hermans, J
    Poppema, S
    Buys, CHCM
    Plukker, JTM
    [J]. DISEASES OF THE COLON & RECTUM, 2001, 44 (03) : 358 - 363
  • [27] Mutational status of TP53 predicts response and survival in leukemia patients
    不详
    [J]. PHARMACOGENOMICS, 2011, 12 (08) : 1089 - 1089
  • [28] Mutational status of TP53 predicts response and survival in leukemia patients
    不详
    [J]. BIOMARKERS IN MEDICINE, 2011, 5 (04) : 420 - 421
  • [29] TP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patients
    Kandioler-Eckersberger, D
    Ludwig, C
    Rudas, M
    Kappel, S
    Janschek, E
    Wenzel, C
    Schlagbauer-Wadl, H
    Mittlböck, M
    Gnant, M
    Steger, G
    Jakesz, R
    [J]. CLINICAL CANCER RESEARCH, 2000, 6 (01) : 50 - 56
  • [30] Combination of genomic instability score and TP53 status for prognosis prediction in lung adenocarcinoma
    Feng, Juan
    Lan, Yang
    Liu, Feng
    Yuan, Ye
    Ge, Jia
    Wei, Sen
    Luo, Hu
    Li, Jianjun
    Luo, Tao
    Bian, Xiuwu
    [J]. NPJ PRECISION ONCOLOGY, 2023, 7 (01)
12345